[HTML][HTML] Согласованное мнение российских экспертов по профилактике, диагностике и лечению сердечно-сосудистой токсичности противоопухолевой …

ЮА Васюк, ГЕ Гендлин, ЕИ Емелина… - Российский …, 2021 - cyberleninka.ru
АВ—атриовентрикулярный (ая) АГ—артериальная гипертензия АД—артериальное
давление АТ—артериальный тромбоз АТО—атеротромботические осложнения АТФ …

The Heart of the Matter: Immune Checkpoint Inhibitors and Immune-Related Adverse Events on the Cardiovascular System

CE Green, J Chacon, BM Godinich, R Hock… - Cancers, 2023 - mdpi.com
Simple Summary Cancer remains one of the leading killers world-wide. In recent years new
drugs to treat cancer that exploit the immune system to attack cancer have been developed …

Cardiotoxicity induced by immune checkpoint inhibitor: The complete insight into mechanisms, monitoring, diagnosis, and treatment

S Ganesh, P Zhong, X Zhou - Frontiers in Cardiovascular Medicine, 2022 - frontiersin.org
Immune checkpoint inhibitors (ICIs) have been taking cancer research by storm as they
provide valuable therapeutic benefits to cancer patients in terms of immunotherapy …

[HTML][HTML] A systematic review of myocarditis induced by immune checkpoint inhibitors: how concerning is the most common cardiotoxicity of immune checkpoint …

A Moradi, A Kodali, C Okoye, DH Klein, I Mohamoud… - Cureus, 2023 - ncbi.nlm.nih.gov
Novel cancer therapies have revolutionized the management of various cancers. An
immune checkpoint inhibitor (ICI) is one of these antitumor medications. ICIs, which are …

Cardiac magnetic resonance‐based layer‐specific strain in immune checkpoint inhibitor‐associated myocarditis

Z Li, R Zhao, C Wang, Y Wang, J Lin, S Zhao… - ESC Heart …, 2024 - Wiley Online Library
Aims To assess the different imaging characteristics between corticosteroid‐sensitive (CS)
and corticosteroid‐refractory (CR) immune checkpoint inhibitor‐associated myocarditis …

Multisystem immune-related adverse events due to toripalimab: Two cases-based review

Y Chen, Y Chen, J Xie, D Liu, X Hong - Frontiers in Cardiovascular …, 2022 - frontiersin.org
Immune checkpoint inhibitors (ICIs) have significantly improved the survival of patients with
advanced tumors. However, immune-related adverse events (irAEs) caused by ICIs …

[HTML][HTML] The role of non-coding RNAs in myocarditis: a narrative review

W Liu, J Hu, S Lu, Z Wang - Annals of Translational Medicine, 2022 - ncbi.nlm.nih.gov
The role of non-coding RNAs in myocarditis: a narrative review - PMC Back to Top Skip to
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

Fulminant myocarditis caused by immune checkpoint inhibitor: a case report and possible treatment inspiration

Z Liu, Y Fan, J Guo, N Bian, D Chen - ESC Heart Failure, 2022 - Wiley Online Library
Immune checkpoint inhibitors (ICIs) have become a new hope for many patients with
advanced cancer by blocking tumour immune evasion. However, with the widespread use of …

Routinary PET/CT imaging for oncological surveillance accompanied by echocardiography may identify early atherosclerotic cardiovascular disease: A case report

AD Michel‐Vázquez, S Luna‐Alcala… - …, 2023 - Wiley Online Library
Atherosclerosis is a disease where plaque builds up in arteries, resulting in harmful
cardiovascular events. Inflammation has a significant role in its progression, starting from the …

[HTML][HTML] Myocardial extracellular volume derived from contrast-enhanced chest computed tomography in longitudinal evaluation of cardiac toxicity in patients treated …

T Wang, B Ouyang, L Tang, L Li… - Quantitative Imaging in …, 2024 - ncbi.nlm.nih.gov
Background The immune-related adverse effects after immune checkpoint inhibitors (ICIs)
treatment have always been a hot topic. Although the incidence of myocarditis is not high …